44 related articles for article (PubMed ID: 21840711)
1. Mechanism-Based Inactivation of
Mellott DM; Torres D; Krieger IV; Cameron SA; Moghadamchargari Z; Laganowsky A; Sacchettini JC; Meek TD; Harris LD
J Am Chem Soc; 2021 Oct; 143(42):17666-17676. PubMed ID: 34664502
[TBL] [Abstract][Full Text] [Related]
2. Covalent Inactivation of
Pham TV; Mellott DM; Moghadamchargari Z; Chen K; Krieger I; Laganowsky A; Sacchettini JC; Meek TD
ACS Chem Biol; 2021 Mar; 16(3):463-470. PubMed ID: 33688722
[TBL] [Abstract][Full Text] [Related]
3. ¹³C metabolic flux analysis identifies an unusual route for pyruvate dissimilation in mycobacteria which requires isocitrate lyase and carbon dioxide fixation.
Beste DJ; Bonde B; Hawkins N; Ward JL; Beale MH; Noack S; Nöh K; Kruger NJ; Ratcliffe RG; McFadden J
PLoS Pathog; 2011 Jul; 7(7):e1002091. PubMed ID: 21814509
[TBL] [Abstract][Full Text] [Related]
4. Heterogeneous multimeric structure of isocitrate lyase in complex with succinate and itaconate provides novel insights into its inhibitory mechanism.
Kwon S; Chun HL; Ha HJ; Lee SY; Park HH
PLoS One; 2021; 16(5):e0251067. PubMed ID: 33951112
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and in Vitro Characterization of Trehalose-Based Inhibitors of Mycobacterial Trehalose 6-Phosphate Phosphatases.
Kapil S; Petit C; Drago VN; Ronning DR; Sucheck SJ
Chembiochem; 2019 Jan; 20(2):260-269. PubMed ID: 30402996
[TBL] [Abstract][Full Text] [Related]
6. Discovery and development of a small molecule library with lumazine synthase inhibitory activity.
Talukdar A; Breen M; Bacher A; Illarionov B; Fischer M; Georg G; Ye QZ; Cushman M
J Org Chem; 2009 Aug; 74(15):5123-34. PubMed ID: 19552377
[TBL] [Abstract][Full Text] [Related]
7. Identification of triazinoindol-benzimidazolones as nanomolar inhibitors of the Mycobacterium tuberculosis enzyme TDP-6-deoxy-d-xylo-4-hexopyranosid-4-ulose 3,5-epimerase (RmlC).
Sivendran S; Jones V; Sun D; Wang Y; Grzegorzewicz AE; Scherman MS; Napper AD; McCammon JA; Lee RE; Diamond SL; McNeil M
Bioorg Med Chem; 2010 Jan; 18(2):896-908. PubMed ID: 19969466
[TBL] [Abstract][Full Text] [Related]
8. Development of NMR and thermal shift assays for the evaluation of
Bhusal RP; Patel K; Kwai BXC; Swartjes A; Bashiri G; Reynisson J; Sperry J; Leung IKH
Medchemcomm; 2017 Nov; 8(11):2155-2163. PubMed ID: 30108733
[TBL] [Abstract][Full Text] [Related]
9. Identification of anti-inflammatory and other biological activities of 3-carboxamide, 3-carbohydrazide and ester derivatives of gatifloxacin.
Sultana N; Arayne MS; Naz A; Mesaik MA
Chem Cent J; 2013 Jan; 7(1):6. PubMed ID: 23316796
[TBL] [Abstract][Full Text] [Related]
10. Itaconate is a covalent inhibitor of the
Kwai BXC; Collins AJ; Middleditch MJ; Sperry J; Bashiri G; Leung IKH
RSC Med Chem; 2021 Jan; 12(1):57-61. PubMed ID: 34046597
[TBL] [Abstract][Full Text] [Related]
11. Advances in mycobacterial isocitrate lyase targeting and inhibitors.
Krátký M; Vinšová J
Curr Med Chem; 2012; 19(36):6126-37. PubMed ID: 23092127
[TBL] [Abstract][Full Text] [Related]
12. Isocitrate lyase: a potential target for anti-tubercular drugs.
Sharma R; Das O; Damle SG; Sharma AK
Recent Pat Inflamm Allergy Drug Discov; 2013 May; 7(2):114-23. PubMed ID: 23506018
[TBL] [Abstract][Full Text] [Related]
13. Identification of natural potent inhibitors against Mycobacterium tuberculosis isocitrate lyase: an in silico study.
Rabaan AA; Halwani MA; Garout M; Turkistani SA; Alsubki RA; Alawfi A; Alshengeti A; Najim MA; Al Kaabi NA; Alqazih TQ; Aseeri AA; Bahitham AS; Alsubaie MA; Alissa M; Aljeldah M
Mol Divers; 2023 Aug; ():. PubMed ID: 37578620
[TBL] [Abstract][Full Text] [Related]
14. Discovery of a Novel Inhibitor Structure of
Duan C; Jiang Q; Jiang X; Zeng H; Wu Q; Yu Y; Yang X
Molecules; 2022 Apr; 27(8):. PubMed ID: 35458645
[TBL] [Abstract][Full Text] [Related]
15. Addressing Latent Tuberculosis: New Advances in Mimicking the Disease, Discovering Key Targets, and Designing Hit Compounds.
Campaniço A; Harjivan SG; Warner DF; Moreira R; Lopes F
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33238468
[TBL] [Abstract][Full Text] [Related]
16.
Kwofie SK; Dankwa B; Odame EA; Agamah FE; Doe LPA; Teye J; Agyapong O; Miller WA; Mosi L; Wilson MD
Molecules; 2018 Jun; 23(7):. PubMed ID: 29954088
[TBL] [Abstract][Full Text] [Related]
17. Potential inhibitors for isocitrate lyase of Mycobacterium tuberculosis and non-M. tuberculosis: a summary.
Lee YV; Wahab HA; Choong YS
Biomed Res Int; 2015; 2015():895453. PubMed ID: 25649791
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of Paracoccidioides lutzii Pb01 isocitrate lyase by the natural compound argentilactone and its semi-synthetic derivatives.
Prado RS; Alves RJ; Oliveira CM; Kato L; Silva RA; Quintino GO; do Desterro Cunha S; de Almeida Soares CM; Pereira M
PLoS One; 2014; 9(4):e94832. PubMed ID: 24752170
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of various 3-nitropropionamides as Mycobacterium tuberculosis isocitrate lyase inhibitor.
Sriram D; Yogeeswari P; Methuku S; Vyas DR; Senthilkumar P; Alvala M; Jeankumar VU
Bioorg Med Chem Lett; 2011 Sep; 21(18):5149-54. PubMed ID: 21840711
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
